Maxcyte (MXCT) Inventory Average (2021 - 2026)

Maxcyte (MXCT) has reported Inventory Average for 6 consecutive years, with $7.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average fell 4.8% year-over-year to $7.7 million in Q2 2026; TTM through Jun 2026 was $7.7 million, a 4.8% decrease from a year earlier, with the FY2025 full-year figure at $8.2 million, down 22.14% from the prior year.
• Inventory Average was $7.7 million for Q2 2026 at Maxcyte, up from $7.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $12.4 million in Q4 2023 and troughed at $5.9 million in Q1 2022.
• A 5-year average of $9.2 million and a median of $8.4 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 87.95% in 2022 and retreated 29.9% in 2025, its largest moves.
• Over 5 years, Inventory Average stood at $8.2 million in 2022, then soared by 50.14% to $12.4 million in 2023, then dropped by 22.03% to $9.7 million in 2024, then fell by 21.49% to $7.6 million in 2025, then gained by 1.79% to $7.7 million in 2026.
• The last three Inventory Average figures came in at $7.7 million (Q2 2026), $7.6 million (Q1 2026), and $7.6 million (Q4 2025), per Business Quant data.